Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

The Journal of Antimicrobial Chemotherapy
Marta SousaMarta Boffito

Abstract

Malaria and tuberculosis (TB) are two major global diseases mostly affecting the developing countries. Their treatment is often complex because of the drugs used, multidrug resistance, drug interactions and logistic problems such as drug availability and access. Patients are treated for TB for a minimum of 6 months and may concomitantly develop and be treated for malaria, especially during the rainy season. Rifampicin, a standard component of combination regimens for treating TB, is a potent inducer of hepatic cytochrome and other metabolic enzymes and is able to influence the pharmacokinetics of many drugs. Rifabutin, another rifamycin used less frequently than rifampicin, can also interact with drugs metabolized through the hepatic cytochromes. The mechanisms of any interaction of rifamycins with drugs used in malaria are not well defined. To complicate matters, acute malaria also plays a role in the pharmacokinetics and pharmacodynamics of drugs (i.e. quinine). The aim of this paper is to review known and potential drug-drug interactions between rifampicin, rifabutin and antimalarial drugs.

References

Jul 1, 1992·Transactions of the Royal Society of Tropical Medicine and Hygiene·M Hassan AlinM Ashton
Aug 4, 1992·Biochemical Pharmacology·K N BangchangD J Back
Jan 1, 1991·Molecular and Biochemical Parasitology·M J GardnerR J Wilson
Oct 1, 1990·Clinical Pharmacokinetics·J Karbwang, N J White
Dec 1, 1994·Antimicrobial Agents and Chemotherapy·J D ColmeneroE Valverde
Mar 1, 1994·Antimicrobial Agents and Chemotherapy·S PukrittayakameeN J White
Mar 1, 1993·Transactions of the Royal Society of Tropical Medicine and Hygiene·M StrathI Wilson
Aug 1, 1995·The Journal of Antimicrobial Chemotherapy·J Luna-HerreraP R Gangadharam
Jul 1, 1995·British Journal of Clinical Pharmacology·S WanwimolrukS Thitiarchakul
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·E G SchuetzJ D Schuetz
Sep 1, 1996·Antimicrobial Agents and Chemotherapy·S RomandF Derouin
Apr 1, 1996·Clinical Pharmacokinetics·S Krishna, N J White
Mar 1, 1997·British Journal of Clinical Pharmacology·H ZhangS Wanwimolruk
Jan 1, 1997·European Journal of Clinical Pharmacology·S PukrittayakameeN J White
Jan 7, 1998·Antimicrobial Agents and Chemotherapy·C A PeloquinR W Jelliffe
Aug 3, 1999·Antimicrobial Agents and Chemotherapy·L E BermudezL S Young
Aug 13, 1999·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·L ConstantinoJ Iley
Dec 1, 1999·Clinical Pharmacology and Therapeutics·R A MirghaniL L Gustafsson
Nov 4, 2000·Clinical Pharmacology and Therapeutics·R A BranchM Romkes
Nov 25, 2000·The Journal of Pharmacy and Pharmacology·W RidtitidM Sunbhanich
Jul 4, 2001·Clinical Pharmacokinetics·W J BurmanC Peloquin
Jul 4, 2001·Clinical Pharmacokinetics·P T Giao, P J de Vries
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Xue-Qing LiCollen M Masimirembwa
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Carolyn L CumminsLeslie Z Benet
Apr 17, 2002·European Journal of Clinical Pharmacology·Mita M ThaparAnders Björkman
May 9, 2002·Archives of Internal Medicine·Christopher K FinchTimothy H Self
Mar 7, 2003·Clinical Pharmacology and Therapeutics·Siegfried DrescherMartin F Fromm
Apr 24, 2003·Antimicrobial Agents and Chemotherapy·S PukrittayakameeN J White
Jun 7, 2003·Toxicology and Applied Pharmacology·Esther F A BrandonJan H M Schellens
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael A WynaldaLarry C Wienkers
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul N NewtonNicholas J White
Sep 12, 2003·Archives of Pharmacal Research·Kyoung-Ah KimSabina Lim
Nov 25, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yvonne Y LauLeslie Z Benet
Oct 7, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lichuan Liu, K Sandy Pang
Oct 26, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tomo DaidojiHiroshi Yokota
Feb 17, 2006·Annals of Clinical Microbiology and Antimicrobials·Jiezhong Chen, Kenneth Raymond
Jun 17, 2006·Biomedical Chromatography : BMC·Deborah-Ann Johnson, Kevin D Smith
Jul 4, 2006·The Journal of Antimicrobial Chemotherapy·Kenneth N Agwuh, Alasdair MacGowan
Sep 26, 2006·Trends in Pharmacological Sciences·Stephanie G Valderramos, David A Fidock
Dec 28, 2006·Human Psychopharmacology·M J EhretA Rathinavelu
Jan 16, 2008·Clinical Pharmacokinetics·Polina I German, Francesca T Aweeka

❮ Previous
Next ❯

Citations

Oct 25, 2012·European Journal of Clinical Pharmacology·Renli TengKathleen Butler
Nov 2, 2011·Internal and Emergency Medicine·Teresita Mazzei
Oct 27, 2011·Chemical Reviews·Cyrille Y BottéChristophe Biot
Jan 8, 2013·The Journal of Antimicrobial Chemotherapy·Gemma L NixonGiancarlo A Biagini
Oct 21, 2009·Antimicrobial Agents and Chemotherapy·Valérie ZellerNicole Desplaces
May 28, 2013·International Journal of Cell Biology·Jasmin LindnerCarsten Wrenger
Jul 6, 2014·Best Practice & Research. Clinical Anaesthesiology·Andrew AbeAdam Marc Kaye
May 5, 2012·Expert Opinion on Drug Metabolism & Toxicology·Yue-Ming WangTaosheng Chen
Nov 10, 2012·Current Medical Research and Opinion·Anne M BaciewiczTimothy H Self
Oct 17, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Thomas E RogersonAngela C Webster
Dec 17, 2015·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·Michael W HyattAllison N Wack
Jun 4, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Andrew StolbachPaul Pham
Jun 29, 2016·AAPS PharmSciTech·Pradip NirbhavaneGopal Krishan Khuller
Dec 22, 2011·Thérapie·Marie-Clémence VerdierUNKNOWN pour le groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique
Nov 3, 2016·Expert Review of Clinical Pharmacology·Bella Devaleenal DanielSoumya Swaminathan
Jul 22, 2011·The Annals of Pharmacotherapy·Terra R VarnerHelmut Albrecht
Aug 5, 2017·Drug Development Research·Arlette Guadalupe Arroyo-LiraAracely Evangelina Chávez-Piña
Dec 6, 2018·Dermatologic Therapy·Elia RosiFrancesca Prignano
Feb 17, 2019·Clinical Pharmacology and Therapeutics·Savannah J McFeelyDan Hartman
Jul 4, 2013·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Marina PinheiroSalette Reis
Mar 27, 2019·Antimicrobial Agents and Chemotherapy·P Brian SmithUNKNOWN Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee
Nov 15, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lies De BockJan Van Bocxlaer
Nov 30, 2019·Journal of Travel Medicine·Jelena LewisJeff Goad
May 5, 2020·PloS One·Joo Young Hong, Ju Han Kim
Feb 9, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·H Manisha YapaAnton Pozniak
Aug 14, 2020·The Journal of Antimicrobial Chemotherapy·Tom G JacobsUNKNOWN WHO Paediatric Antiretroviral Working Group
Jul 20, 2017·Malaria Journal·Gayatri RamakrishnanNarayanaswamy Srinivasan
Oct 25, 2017·Malaria Journal·Maarten van der VeldenJan B Koenderink
Mar 1, 2019·Antimicrobial Resistance and Infection Control·Muhammad MiftahussururYoshio Yamaoka
Feb 29, 2020·Journal of Clinical Pharmacology·Juntra Karbwang, Kesara Na-Bangchang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.